Skip to main content

(Approval lapsed) HydrALAZINE Hydrochloride Tablets USP 25mg (Camber, USA)

Section 19A approved medicine
(Approval lapsed) HydrALAZINE Hydrochloride Tablets USP 25mg (Camber, USA)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
ALPHAPRESS 25 hydralazine hydrochloride 25mg tablet bottle - ARTG 17575
Indication(s)

Hypertension (drug resistant, moderate to severe) As supplementary medication for use together with other antihypertensives such as beta-blockers and diuretics; the complementary mechanisms of action of such combined therapy enable the drugs to exert their antihypertensive effects at low doses; in addition, unwanted accompanying effects of the individual substances are either partially offset or even cancelled out.

Images
Picture of Hydralazine hydrochloride tablets USP 25mg bottle

Help us improve the Therapeutic Goods Administration site